Difference between revisions of "DIG5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(17 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 +
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Digestive System Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Digestive System Tumours (5th Edition) Content</big>
Line 16: Line 19:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
|-
 +
|
 +
====CHAPTER 2 (TUMOURS OF THE OESOPHAGUS)====
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
 
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
 
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
Line 116: Line 140:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
+
|
−
|Disease
+
====CHAPTER 3 (TUMOURS OF THE STOMACH)====
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|-
 +
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 259: Line 304:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
−
|-
+
----<br />
−
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
+
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 292: Line 336:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
+
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 303: Line 347:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
+
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 314: Line 358:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
+
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 325: Line 369:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
+
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 336: Line 380:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 5 (TUMOURS OF THE APPENDIX)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
−
|-
+
----<br />
−
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
+
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
 
|Disease
 
|Disease
 
|
 
|
Line 369: Line 412:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
+
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 423:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
+
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 391: Line 434:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
+
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 402: Line 445:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
+
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 413: Line 456:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
+
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
 
|Disease
 
|Disease
 
|
 
|
Line 435: Line 488:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_condyloma|Anal condyloma]]
+
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 499:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
+
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
 
|Disease
 
|Disease
 
|
 
|
Line 457: Line 510:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
+
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 468: Line 521:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
+
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 479: Line 532:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 7 (TUMOURS OF THE ANAL CANAL)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
−
|-
+
----<br />
−
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
+
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
 
|Disease
 
|Disease
 
|
 
|
Line 512: Line 564:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
+
|[[DIG5:Anal_condyloma|Anal condyloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 523: Line 575:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
+
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
 
|Disease
 
|Disease
 
|
 
|
Line 534: Line 586:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
+
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 545: Line 597:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
+
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 556: Line 608:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
+
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 567: Line 619:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
+
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
 
|Disease
 
|Disease
 
|
 
|
Line 589: Line 651:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
+
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 662:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
+
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 611: Line 673:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
+
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 622: Line 684:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
+
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 633: Line 695:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
+
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 644: Line 706:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
+
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
 
|Disease
 
|Disease
 
|
 
|
Line 655: Line 717:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
+
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 666: Line 728:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
+
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 677: Line 739:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
+
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
 
|Disease
 
|Disease
 
|
 
|
Line 688: Line 750:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
+
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 782:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
+
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 721: Line 793:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
+
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
 
|Disease
 
|Disease
 
|
 
|
Line 732: Line 804:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
+
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 743: Line 815:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
+
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
 
|Disease
 
|Disease
 
|
 
|
Line 754: Line 826:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
+
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 765: Line 837:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
+
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
 
|Disease
 
|Disease
 
|
 
|
Line 776: Line 848:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 10 (TUMOURS OF THE PANCREAS)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
+
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 880:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
+
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 809: Line 891:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Insulinoma|Insulinoma]]
+
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 902:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Gastrinoma|Gastrinoma]]
+
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 831: Line 913:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:VIPoma|VIPoma]]
+
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 842: Line 924:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Glucagonoma|Glucagonoma]]
+
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 853: Line 935:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Somatostatinoma|Somatostatinoma]]
+
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 864: Line 946:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
+
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 875: Line 957:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
+
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 886: Line 968:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
+
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 897: Line 979:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
+
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
 
|Disease
 
|Disease
 
|
 
|
Line 908: Line 990:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
+
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 919: Line 1,001:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
+
|[[DIG5:Insulinoma|Insulinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 930: Line 1,012:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
+
|[[DIG5:Gastrinoma|Gastrinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 941: Line 1,023:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
+
|[[DIG5:VIPoma|VIPoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 952: Line 1,034:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
+
|[[DIG5:Glucagonoma|Glucagonoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 963: Line 1,045:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
+
|[[DIG5:Somatostatinoma|Somatostatinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 974: Line 1,056:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
+
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 985: Line 1,067:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
+
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 996: Line 1,078:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
+
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,007: Line 1,089:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
+
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,018: Line 1,100:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM)====
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 +
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,040: Line 1,132:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
+
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,051: Line 1,143:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
+
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,062: Line 1,154:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
+
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,073: Line 1,165:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
+
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,084: Line 1,176:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
+
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,095: Line 1,187:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
+
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,106: Line 1,198:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
+
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,117: Line 1,209:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
+
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,128: Line 1,220:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
+
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,139: Line 1,231:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Desmoid_fibromatosis_|Desmoid fibromatosis]]
+
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
====CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM)====
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|
 +
----<br />
 +
|-
 +
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Desmoid_fibromatosis_|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Inflammatory_fibroid_polyp|Inflammatory fibroid polyp]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Plexiform_fibromyxoma|Plexiform fibromyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[DIG5:Leiomyoma|Leiomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,150: Line 1,439:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[DIG5:Leiomyosarcoma|Leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,161: Line 1,450:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Lipoma|Lipoma]]
+
|[[DIG5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,172: Line 1,461:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Inflammatory_fibroid_polyp|Inflammatory fibroid polyp]]
+
|[[DIG5:Haemangioma|Haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,183: Line 1,472:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Plexiform_fibromyxoma|Plexiform fibromyxoma]]
+
|[[DIG5:Epithelioid_haemangioendothelioma_(prev_Vascular_Tumours_in_Liver)|Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver)]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,194: Line 1,483:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Leiomyoma|Leiomyoma]]
+
|[[DIG5:Kaposi_sarcoma|Kaposi sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,205: Line 1,494:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Leiomyosarcoma|Leiomyosarcoma]]
+
|[[DIG5:Angiosarcoma|Angiosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,216: Line 1,505:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
+
|[[DIG5:Glomus_tumour_|Glomus tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,227: Line 1,516:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Haemangioma|Haemangioma]]
+
|[[DIG5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,238: Line 1,527:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Epithelioid_haemangioendothelioma_(prev_Vascular_Tumours_in_Liver)|Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver)]]
+
|[[DIG5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,249: Line 1,538:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[DIG5:Granular_cell_tumour|Granular cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,260: Line 1,549:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Angiosarcoma|Angiosarcoma]]
+
|[[DIG5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,271: Line 1,560:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Glomus_tumour_|Glomus tumour]]
+
|[[DIG5:Ganglioneuroma_and_ganglioneuromatosis_|Ganglioneuroma and ganglioneuromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,282: Line 1,571:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
+
|[[DIG5:PEComa,_including_angiomyolipoma_|PEComa, including angiomyolipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,293: Line 1,582:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Schwannoma|Schwannoma]]
+
|[[DIG5:Mesenchymal_hamartoma_of_the_liver|Mesenchymal hamartoma of the liver]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,304: Line 1,593:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Granular_cell_tumour|Granular cell tumour]]
+
|[[DIG5:Calcifying_nested_stromal-epithelial_tumour_of_the_liver|Calcifying nested stromal-epithelial tumour of the liver]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,315: Line 1,604:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Perineurioma|Perineurioma]]
+
|[[DIG5:Synovial_sarcoma|Synovial sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,326: Line 1,615:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Ganglioneuroma_and_ganglioneuromatosis_|Ganglioneuroma and ganglioneuromatosis]]
+
|[[DIG5:Gastrointestinal_clear_cell_sarcoma_/_malignant_gastrointestinal_neuroectodermal_tumour|Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,337: Line 1,626:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:PEComa,_including_angiomyolipoma_|PEComa, including angiomyolipoma]]
+
|[[DIG5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,348: Line 1,637:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Mesenchymal_hamartoma_of_the_liver|Mesenchymal hamartoma of the liver]]
 
−
|Disease
 
 
|
 
|
 +
====CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM)====
 +
|
 +
----<br />
 +
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|
 
|
 +
----<br />
 
|-
 
|-
−
|[[DIG5:Calcifying_nested_stromal-epithelial_tumour_of_the_liver|Calcifying nested stromal-epithelial tumour of the liver]]
+
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,370: Line 1,669:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Synovial_sarcoma|Synovial sarcoma]]
+
|[[DIG5:Germ_cell_tumours_of_the_digestive_system|Germ cell tumours of the digestive system]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,381: Line 1,680:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Gastrointestinal_clear_cell_sarcoma_/_malignant_gastrointestinal_neuroectodermal_tumour|Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour]]
+
|[[DIG5:Digestive_system_metastases_|Digestive system metastases]]
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[DIG5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
 
 
|Disease
 
|Disease
 
|
 
|
Line 1,414: Line 1,691:
 
|
 
|
 
|-
 
|-
−
|[[DIG5:Germ_cell_tumours_of_the_digestive_system|Germ cell tumours of the digestive system]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[DIG5:Digestive_system_metastases_|Digestive system metastases]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
−
|-
+
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF THE DIGESTIVE SYSTEM)====
−
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF THE DIGESTIVE SYSTEM)
 
 
|
 
|
 
----<br />
 
----<br />
Line 1,458: Line 1,714:
 
|[[DIG5:Lynch_syndrome|Lynch syndrome]]
 
|[[DIG5:Lynch_syndrome|Lynch syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[DIG5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|[[DIG5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[DIG5:GAPPS_and_other_fundic_gland_polyposes|GAPPS and other fundic gland polyposes]]
 
|[[DIG5:GAPPS_and_other_fundic_gland_polyposes|GAPPS and other fundic gland polyposes]]
Line 1,535: Line 1,791:
 
|[[DIG5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 
|[[DIG5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[DIG5:Cowden_syndrome|Cowden syndrome]]
 
|[[DIG5:Cowden_syndrome|Cowden syndrome]]
Line 1,553: Line 1,809:
 
|
 
|
 
|
 
|
−
|Named based on DIG5 book
+
|Named based on this book. Template added 7/12/24. Also, content in online WHO HAN5, CNS5, FEMA5, BRST5.
 
|-
 
|-
 
|}
 
|}

Latest revision as of 13:37, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Digestive System Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (TUMOURS OF THE OESOPHAGUS)









Oesophageal squamous papilloma Disease
Barrett dysplasia Disease
Oesophageal squamous dysplasia Disease
Adenocarcinoma of the oesophagus and oesophagogastric junction NOS Disease
Oesophageal adenoid cystic carcinoma Disease
Oesophageal adenosquamous and mucoepidermoid carcinomas Disease
Oesophageal squamous cell carcinoma NOS Disease
Oesophageal undifferentiated carcinoma Disease
Oesophageal neuroendocrine neoplasms Disease

CHAPTER 3 (TUMOURS OF THE STOMACH)









Fundic gland polyps Disease
Gastric hyperplastic polyps Disease
Gastric dysplasia Disease
Intestinal-type gastric adenoma Disease
Foveolar-type adenoma Disease
Gastric pyloric gland adenoma Disease
Oxyntic gland adenoma Disease
Gastric adenocarcinoma Disease
Gastric squamous cell carcinoma Disease
Gastric adenosquamous carcinoma Disease
Gastric undifferentiated carcinoma Disease
Gastroblastoma Disease
Gastric neuroendocrine neoplasms Disease

CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA)









Non-ampullary adenoma Disease
Ampullary adenoma Disease
Non-ampullary adenocarcinoma Disease
Ampullary adenocarcinoma Disease
Small intestinal and ampullary neuroendocrine neoplasms Disease

CHAPTER 5 (TUMOURS OF THE APPENDIX)









Appendiceal serrated lesions and polyps Disease
Appendiceal mucinous neoplasm Disease
Appendiceal adenocarcinoma Disease
Appendiceal goblet cell adenocarcinoma Disease
Appendiceal neuroendocrine neoplasms Disease

CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM)









Colorectal serrated lesions and polyps Disease
Conventional colorectal adenoma Disease
Inflammatory bowel disease-associated dysplasia of the colorectum Disease
Colorectal adenocarcinoma Disease
Colorectal neuroendocrine neoplasms Disease

CHAPTER 7 (TUMOURS OF THE ANAL CANAL)









Inflammatory cloacogenic polyp Disease
Anal condyloma Disease
Anal squamous dysplasia (intraepithelial neoplasia) Disease
Anal squamous cell carcinoma Disease
Anal adenocarcinoma Disease
Anal neuroendocrine neoplasms Disease

CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS)









Focal nodular hyperplasia of the liver Disease
Hepatocellular adenoma Disease
Hepatocellular carcinoma Disease
Hepatoblastoma Disease
Bile duct adenoma Disease
Biliary adenofibroma Disease
Mucinous cystic neoplasm of the liver and biliary system Disease
Intrahepatic cholangiocarcinoma Disease
Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma Disease
Hepatic neuroendocrine neoplasms Disease

CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS)









Pyloric gland adenoma of the gallbladder Disease
Biliary intraepithelial neoplasia Disease
Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm) Disease
Intraductal papillary neoplasm of the bile ducts Disease
Carcinoma of the gallbladder Disease
Carcinoma of the extrahepatic bile ducts Disease
Neuroendocrine neoplasms of the gallbladder and bile ducts Disease

CHAPTER 10 (TUMOURS OF THE PANCREAS)









Acinar cystic transformation of the pancreas Disease
Serous neoplasms of the pancreas Disease
Pancreatic intraepithelial neoplasia Disease
Pancreatic intraductal papillary mucinous neoplasm Disease
Pancreatic intraductal oncocytic papillary neoplasm Disease
Pancreatic intraductal tubulopapillary neoplasm Disease
Pancreatic mucinous cystic neoplasm Disease
Pancreatic ductal adenocarcinoma Disease
Pancreatic acinar cell carcinoma Disease
Pancreatoblastoma Disease
Solid pseudopapillary neoplasm of the pancreas Disease
Non-functioning pancreatic neuroendocrine tumours Disease
Insulinoma Disease
Gastrinoma Disease
VIPoma Disease
Glucagonoma Disease
Somatostatinoma Disease
ACTH-producing neuroendocrine tumour Disease
Serotonin-producing neuroendocrine tumour Disease
Pancreatic neuroendocrine carcinoma Disease
Pancreatic MiNENs Disease

CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM)









Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract Disease
Duodenal-type follicular lymphoma Disease
Enteropathy-associated T-cell lymphoma Disease
Monomorphic epitheliotropic intestinal T-cell lymphoma Disease
Intestinal T-cell lymphoma NOS Disease
Indolent T-cell lymphoproliferative disorder of the GI tract Disease
Hepatosplenic T-cell lymphoma Disease
EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract Disease
Diffuse large B-cell lymphoma Disease
Follicular lymphoma Disease
Mantle cell lymphoma Disease
Burkitt lymphoma Disease
Plasmablastic lymphoma Disease
Posttransplant lymphoproliferative disorders Disease
Extranodal NK/T-cell lymphoma Disease
Systemic mastocytosis Disease
Langerhans cell histiocytosis Disease
Follicular dendritic cell sarcoma Disease
Histiocytic sarcoma Disease

CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM)









Gastrointestinal stromal tumour Disease
Inflammatory myofibroblastic tumour Disease
Desmoid fibromatosis Disease
Solitary fibrous tumour Disease
Lipoma Disease
Inflammatory fibroid polyp Disease
Plexiform fibromyxoma Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Haemangioma Disease
Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver) Disease
Kaposi sarcoma Disease
Angiosarcoma Disease
Glomus tumour Disease
Lymphangioma and lymphangiomatosis Disease
Schwannoma Disease
Granular cell tumour Disease
Perineurioma Disease
Ganglioneuroma and ganglioneuromatosis Disease
PEComa, including angiomyolipoma Disease
Mesenchymal hamartoma of the liver Disease
Calcifying nested stromal-epithelial tumour of the liver Disease
Synovial sarcoma Disease
Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour Disease
Embryonal sarcoma of the liver Disease

CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM)









Mucosal melanoma of the digestive system Disease
Germ cell tumours of the digestive system Disease
Digestive system metastases Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF THE DIGESTIVE SYSTEM)









Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
GAPPS and other fundic gland polyposes Disease
Serrated polyposis Disease
Hereditary diffuse gastric cancer Disease
Familial pancreatic cancer Disease
Juvenile polyposis syndrome Disease
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Cowden syndrome Disease Named based on this book. Template added 7/12/24. Also, content in online WHO HAN5, CNS5, FEMA5, BRST5.
Retrieved from "https://ccga.io/index.php?title=DIG5:Volunteer_Assignments_and_Opportunities&oldid=15397"